FDA proposes framework clinical trial designs to guide Bayesian methods, improving efficiency in drug development for rare and pediatric conditions.

The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in clinical trials, formally recognizing Bayesian approaches that align with the ...

The FDA’s new draft guidance on Bayesian methodology signals a shift toward more flexible, data-driven clinical trial designs, enabling sponsors to use prior data and adaptive approaches to improve ...

In a world of uncertainty and shifting narratives, this post proposes a new model for investing: Bayesian edge investing. Unlike modern portfolio theory, which assumes equilibrium and perfect ...

Researchers have employed Bayesian neural network approaches to evaluate the distributions of independent and cumulative ...

Association of intestinal exfoliome and Prevotellaceae with toxicity and clinical outcome during immune-checkpoint blockade. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...